Biodexa Pharmaceuticals (MTP) Short Interest Ratio & Short Volume → New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad) Free MTP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Biodexa Pharmaceuticals Short Interest DataCurrent Short Volume84,900 sharesPrevious Short Volume59,900 sharesChange Vs. Previous Month+41.74%Dollar Volume Sold Short$118,860.00Short Interest Ratio / Days to Cover1.6Last Record DateMarch 15, 2023Outstanding Shares21,670,000 sharesPercentage of Shares Shorted0.39%Today's Trading Volume164,300 sharesAverage Trading Volume57,354 sharesToday's Volume Vs. Average286% Short Selling Biodexa Pharmaceuticals ? Sign up to receive the latest short interest report for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTP Short Interest Over TimeMTP Days to Cover Over TimeMTP Percentage of Float Shorted Over Time Ad InvestorPlaceNow Open: Crypto emergency updateDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. Biodexa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202384,900 shares $118,860.00 +41.7%N/A1.6 $1.40 2/28/202359,900 shares $31,148.00 +0.5%N/A1.2 $0.52 2/15/202359,600 shares $37,548.00 +111.4%N/A1.3 $0.63 1/31/202328,200 shares $19,742.82 +18.0%N/A0.7 $0.70 1/15/202323,900 shares $15,535.00 -38.2%N/A0.8 $0.65 12/30/202238,700 shares $38,119.50 +26.9%N/A2 $0.99 Get the Latest News and Ratings for MTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/15/202230,500 shares $24,403.05 +254.7%N/A1.7 $0.80 11/30/20228,600 shares $13,674.00 -1.2%N/A0.4 $1.59 11/15/20228,700 shares $13,892.16 +6.1%N/A0.4 $1.60 10/31/20228,200 shares $15,908.00 +310.0%N/A0.3 $1.94 10/15/20222,000 shares $3,848.60 -39.4%N/A0.1 $1.92 9/30/20223,300 shares $6,138.00 -61.6%N/A0.1 $1.86 9/15/20228,600 shares $28,638.00 -74.2%N/A0.4 $3.33 8/31/202233,300 shares $24,642.00 +69.0%N/A0.7 $0.74 8/15/202219,700 shares $14,676.50 -63.3%N/A0.1 $0.75 7/31/202253,700 shares $35,168.13 +47.9%N/A0.3 $0.65 7/15/202236,300 shares $26,136.00 -44.8%N/A0.2 $0.72 6/30/202265,800 shares $35,532.00 -24.2%N/A0.3 $0.54 6/15/202286,800 shares $44,935.49 +617.4%N/A0.4 $0.52 5/31/202212,100 shares $7,578.46 -28.8%N/A0.1 $0.63 5/15/202217,000 shares $8,924.98 +794.7%N/A0.3 $0.52 4/30/20221,900 shares $1,235.00 -93.7%N/A0 $0.65 4/15/202230,100 shares $25,886.00 -28.8%N/A0.5 $0.86 3/31/202242,300 shares $37,224.00 +6.0%N/A0.7 $0.88 3/15/202239,900 shares $32,953.37 +17.0%N/A0.5 $0.83 2/28/202234,100 shares $33,452.10 -55.3%N/A0.3 $0.98 2/15/202276,300 shares $76,071.10 +149.4%N/A0.6 $1.00 1/31/202230,600 shares $30,906.00 -42.8%N/A0.2 $1.01 1/15/202253,500 shares $60,455.00 +59.7%N/A0.4 $1.13 12/31/202133,500 shares $35,175.00 -83.7%N/A0.2 $1.05 12/15/2021205,800 shares $234,612.00 +53.5%N/A1.6 $1.14 11/30/2021134,100 shares $195,786.00 +9.2%N/A1.4 $1.46 11/15/2021122,800 shares $200,164.00 -31.3%N/A1.2 $1.63 10/29/2021178,700 shares $303,790.00 +19.1%N/A1.8 $1.70 10/15/2021150,000 shares $255,750.00 +1.6%N/A1.4 $1.71 9/30/2021147,600 shares $256,824.00 -12.4%N/A1.2 $1.74 9/15/2021168,500 shares $291,505.00 +1.9%N/A1.1 $1.73 8/31/2021165,400 shares $302,682.00 -34.0%N/A0.1 $1.83 8/13/2021250,600 shares $455,315.14 -9.4%N/A0.1 $1.82 7/30/2021276,700 shares $514,662.00 +0.8%N/A0.1 $1.86You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. MTP Short Interest - Frequently Asked Questions What is Biodexa Pharmaceuticals' current short interest? Short interest is the volume of Biodexa Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 84,900 shares of MTP short. Learn More on Biodexa Pharmaceuticals' current short interest. What is a good short interest ratio for Biodexa Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MTP shares currently have a short interest ratio of 2.0. Learn More on Biodexa Pharmaceuticals's short interest ratio. Is Biodexa Pharmaceuticals' short interest increasing or decreasing? Biodexa Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 84,900 shares, an increase of 41.7% from the previous total of 59,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biodexa Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biodexa Pharmaceuticals: Xenetic Biosciences Inc (0.14%), First Wave BioPharma, Inc. (3.04%), Cadrenal Therapeutics, Inc. (0.50%), Ainos, Inc. (4.81%), Protagenic Therapeutics, Inc. (0.32%), Hoth Therapeutics, Inc. (5.00%), Vaccinex, Inc. (1.17%), Avenue Therapeutics, Inc. (0.64%), Shuttle Pharmaceuticals Holdings, Inc. (0.72%), Enveric Biosciences, Inc. (4.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Biodexa Pharmaceuticals stock? Short selling MTP is an investing strategy that aims to generate trading profit from Biodexa Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biodexa Pharmaceuticals? A short squeeze for Biodexa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MTP, which in turn drives the price of the stock up even further. How often is Biodexa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTP, twice per month. The most recent reporting period available is March, 15 2023. More Short Interest Resources from MarketBeat Related Companies: XBIO Short Squeeze FWBI Short Squeeze CVKD Short Squeeze AIMD Short Squeeze PTIX Short Squeeze HOTH Short Squeeze VCNX Short Squeeze ATXI Short Squeeze SHPH Short Squeeze ENVB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressYour Money is Not SafeAmerican AlternativeHow Biden has already won 2024Porter & CompanyMan Who Predicted 2008: “This Will be Worse.”AltimetryA.I. Pioneer Issues Urgent Warning to AmericansTradeSmithBUY ALERT: Billionaires piling into this asset classReagan Gold Group